Literature DB >> 33232744

Cox regression model of prognostic factors for delayed neuropsychiatric sequelae in patients with acute carbon monoxide poisoning: A prospective observational study.

Sangsoo Han1, Sungwoo Choi1, Sangun Nah1, Sun-Uk Lee2, Young Soon Cho1, Gi Woon Kim1, Young Hwan Lee3.   

Abstract

OBJECTIVE: A major challenge for physicians is to identify patients with acute carbon monoxide (CO) poisoning who are likely to develop delayed neuropsychiatric sequelae (DNS). DNS is defined as neuropsychological sequelae that develops after 2-40 days of lucid interval after CO intoxication. Currently, there is no consensus on factors that predict the prognosis of CO poisoning. Thus, the purpose of this study was to identify factors predicting the development of DNS using a Cox regression model.
METHODS: This prospective observational study included 310 CO-poisoned patients admitted to an emergency department in South Korea from July 2017 to February 2020. Demographic, clinical, and laboratory data were analyzed. Kaplan-Meier curves were constructed to estimate the cumulative incidence of DNS. A multivariate Cox regression model was used to identify the main predictors of the development of DNS.
RESULTS: The incidence of DNS was 18.8 %, and the median onset time was 23.7 days (interquartile range, 14-30 days). The Kaplan-Meier survival curve showed that a serum creatine kinase (CK) level > 175.5 U/L and initial Glasgow Coma Scale (GCS) score ≤ 9 were associated with a higher cumulative incidence of DNS (log-rank test; p < 0.01 and p = 0.02, respectively). Cox regression analysis showed that a serum CK level > 175.5 U/L (hazard ratio [HR]: 2.862, 95 % confidence interval [CI]: 1.491-5.496; p < 0.01) and an initial GCS ≤ 9 (HR: 2.081, 95 % CI: 1.048-4.131; p = 0.04) were significant prognostic factors.
CONCLUSION: In acute CO poisoning, an initial GCS score ≤ 9 and serum CK level > 175.5 U/L are significant predictors of DNS development.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carbon monoxide poisoning; Creatine kinase; Kaplan–Meier analysis

Year:  2020        PMID: 33232744     DOI: 10.1016/j.neuro.2020.11.006

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  6 in total

1.  Carbon Monoxide Poisoning was Associated With Lifetime Suicidal Ideation: Evidence From A Population-Based Cross-Sectional Study in Hebei Province, China.

Authors:  Long Sun; Keqing Li; Yunshu Zhang; Lili Zhang
Journal:  Int J Public Health       Date:  2022-06-15       Impact factor: 5.100

Review 2.  Association between Glasgow Coma Scale in Early Carbon Monoxide Poisoning and Development of Delayed Neurological Sequelae: A Meta-Analysis.

Authors:  Myeong Namgung; Jaehoon Oh; Chiwon Ahn; Chan Woong Kim; Heekyung Lee; Hyunggoo Kang
Journal:  J Pers Med       Date:  2022-04-14

3.  Identification of key genes associated with esophageal adenocarcinoma based on bioinformatics analysis.

Authors:  Weifeng Qi; Rongyang Li; Lin Li; Shuhai Li; Huiying Zhang; Hui Tian
Journal:  Ann Transl Med       Date:  2021-12

Review 4.  Association between Early Phase Serum Lactate Levels and Occurrence of Delayed Neuropsychiatric Sequelae in Adult Patients with Acute Carbon Monoxide Poisoning: A Systematic Review and Meta-Analysis.

Authors:  Heekyung Lee; Jaehoon Oh; Hyunggoo Kang; Chiwon Ahn; Myeong Namgung; Chan Woong Kim; Wonhee Kim; Young Seo Kim; Hyungoo Shin; Tae Ho Lim
Journal:  J Pers Med       Date:  2022-04-18

5.  Derivation and Validation of a Score for Predicting Poor Neurocognitive Outcomes in Acute Carbon Monoxide Poisoning.

Authors:  Sung Hwa Kim; Yoonsuk Lee; Soo Kang; Jin Hui Paik; Hyun Kim; Yong Sung Cha
Journal:  JAMA Netw Open       Date:  2022-05-02

6.  Factors Predicting Acute Brain Injury in Cases of Carbon Monoxide Poisoning: A Prospective Registry-Based Study.

Authors:  Hoon Lim; Young Hwan Lee; Sangun Nah; Sungwoo Choi; Young Soon Cho; Gi Woon Kim; Ji Eun Moon; Sangsoo Han
Journal:  Toxics       Date:  2021-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.